This new partnership will provide integrated end-to-end solutions from sample to report for whole genome nanopore sequencing in future clinical applications.
Press Releases Partnerships News
Lausanne, Switzerland, October 17,2023 – Saphetor SA today announces that it is partnering with world-leading healthcare intelligence and clinical research organization ICON to develop an innovative approach to support the planning and execution of...
Press Releases Partnerships News
When we ask people what they value most about VarSome, the most common response is “the classifiers”. In building our germline and somatic variant classifiers, we automated a very time-consuming and labor-intensive process. We apply the relevant...
VarSome.com VarSome Clinical VarSome.com Premium VarSome Team
Saphetor are taking part in the Genomics Unlocked Webinar Series, as part of a partnership with MGI Europe. The webinar, Clinical Exomes: Sequencing to Reporting, demonstrates the full clinical exome workflow from sample to report generation...
Saphetor is exhibiting at this year's European Society of Human Genetics conference in Glasgow, Scotland.
Saphetor Sa, A Swiss precision medicine company and creator of the VarSome suite of bioinformatics solutions, today announced the appointment of Maarten Kempen as Chief Commercial Officer, effective February 1st, 2023. Kempen will be responsible...
Our Head of Regulatory Affairs and Quality Assurance, Amélie Martinez, was featured in Inside Precision Medicine in an interview covering the upcoming impact and practical considerations labs are facing regarding IVDR.
Abu Dhabi, October 24, 2022: In a step aimed at boosting its clinical genomics capabilities in the region and beyond, G42 Healthcare, Abu Dhabi-based leading AI health-tech company, has announced a partnership with Saphetor SA, a Swiss precision...
Press Releases Partnerships News
Conferences Partnerships Events News
RIYADH, Kingdom of Saudi Arabia--(BUSINESS WIRE)--King Faisal Specialist Hospital and Research Centre (KFSH&RC) will integrate Saphetor’s proprietary human genome variant interpretation engine, VarSome, into its research and clinical genomics...
Press Releases Partnerships News
Lausanne, Switzerland - September 15, 2022 - Saphetor SA, a Switzerland-based precision medicine company recognized for its industry leading variant interpretation platform VarSome, has been successfully selected as one of the twelve companies to...
Press Releases Partnerships News
VarSome Suite is brought to you by Saphetor SA.
© 2023 Saphetor SA – All Rights Reserved.